The Queensland-Pfizer Program for Diabetes and Cardiovascular Drug Discovery (2012-2014)

Abstract

Type 2 diabetes, obesity and cardiovascular diseases threaten the lives and quality of life of many Queenslanders, impacting on Queensland health and economic prosperity.

Experts

Professor David Fairlie

Centre Director of The Centre for C: Centre for Chemistry and Drug Discovery; Institute for Molecular Bioscience

Affiliate of ARC COE for Innovation: ARC Centre of Excellence for Innovations in Peptide and Protein Science; Institute for Molecular Bioscience

Centre Director of Institute for Mo: Institute for Molecular Bioscience

NHMRC Leadership Fellow and Group L: Institute for Molecular Bioscience

David Fairlie

David Fairlie

Professor David Craik

Affiliate of The Centre for Chemist: Centre for Chemistry and Drug Discovery; Institute for Molecular Bioscience

Affiliate of Centre for Marine Scie: Centre for Marine Science; Faculty of Science

Centre Director of ARC COE for Inno: ARC Centre of Excellence for Innovations in Peptide and Protein Science; Institute for Molecular Bioscience

Affiliate Professor of School of Bi: School of Biomedical Sciences; Faculty of Medicine

UQ Laureate Fellow - GL: Institute for Molecular Bioscience

David Craik

David Craik